About the Company/Team

Cellino Biotech, Inc. is a biotechnology company focused on advancing autonomous, closed biomanufacturing for personalized regenerative medicines. The company aims to revolutionize the production of stem cell-derived therapies by automating the manufacturing process, which has traditionally been labor-intensive and costly. By leveraging high-speed laser editing and machine learning, Cellino's platform enables the scalable production of patient-specific cells, which can be used to treat chronic diseases such as Parkinson's and diabetes. With significant funding and recognition in the biotech community, Cellino is positioned to lead in the regenerative medicine market, addressing the growing demand for personalized therapies.